Sirona Biochem (CVE:SBM) Stock Price Down 15.4% – Here’s What Happened

Sirona Biochem Corp. (CVE:SBMGet Free Report)’s share price traded down 15.4% on Wednesday . The stock traded as low as C$0.06 and last traded at C$0.06. 131,500 shares changed hands during trading, an increase of 68% from the average session volume of 78,329 shares. The stock had previously closed at C$0.07.

Sirona Biochem Stock Performance

The company has a quick ratio of 2.41, a current ratio of 0.34 and a debt-to-equity ratio of 219.21. The stock has a fifty day moving average price of C$0.06 and a two-hundred day moving average price of C$0.07. The company has a market capitalization of C$15.41 million, a price-to-earnings ratio of -6.00 and a beta of -0.03.

About Sirona Biochem

(Get Free Report)

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.

Recommended Stories

Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.